Is Catalyst Biosciences Inc (CBIO) a Good Choice in Biotechnology Wednesday?

Wednesday, June 22, 2022 01:17 PM | InvestorsObserver Analysts

Mentioned in this article

Is Catalyst Biosciences Inc (CBIO) a Good Choice in Biotechnology Wednesday?

A rating of 95 puts Catalyst Biosciences Inc (CBIO) near the top of the Biotechnology industry according to InvestorsObserver. Catalyst Biosciences Inc's score of 95 means it scores higher than 95% of stocks in the industry. Catalyst Biosciences Inc also received an overall rating of 77, putting it above 77% of all stocks. Biotechnology is ranked 38 out of the 148 industries.

CBIO has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on CBIO!

See Full CBIO Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 77 would rank higher than 77 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Catalyst Biosciences Inc Stock Today?

Catalyst Biosciences Inc (CBIO) stock is trading at $1.42 as of 1:13 PM on Wednesday, Jun 22, a gain of $0.07, or 5.19% from the previous closing price of $1.35. The stock has traded between $1.37 and $1.45 so far today. Volume today is light. So far 207,160 shares have traded compared to average volume of 12,224,171 shares. Click Here to get the full Stock Report for Catalyst Biosciences Inc stock.